Want to join the conversation?
$XRAY said cash flow from operating activities during 2Q16 was $187.4MM compared to $145.6MM last year. Cash used in investing activities was $18.1MM compared to $14.4MM in the prior year. The YoverY increases were mainly related to the consolidation with Sirona. The company ended 2Q16 with a cash balance of $311.6MM.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.